nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability
|
Dixon, J. Michael |
|
2010 |
125 |
3 |
p. 741-749 |
artikel |
2 |
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
|
Hershman, Dawn L. |
|
2010 |
125 |
3 |
p. 767-774 |
artikel |
3 |
Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis
|
Yang, Dae Sik |
|
2010 |
125 |
3 |
p. 849-853 |
artikel |
4 |
A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance
|
Wernicke, A. Gabriella |
|
2010 |
125 |
3 |
p. 893-902 |
artikel |
5 |
Breast cancer in the supraclavicular region: is the horse out of the barn?
|
Jagsi, Reshma |
|
2010 |
125 |
3 |
p. 823-825 |
artikel |
6 |
Breast cancer prognostic markers in the post-genomic era
|
Pusztai, Lajos |
|
2010 |
125 |
3 |
p. 647-650 |
artikel |
7 |
Changes in leadership of breast cancer research and treatment
|
Lippman, Marc E. |
|
2011 |
125 |
3 |
p. 605 |
artikel |
8 |
Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes
|
Zeng, Xiao-Hua |
|
2010 |
125 |
3 |
p. 715-727 |
artikel |
9 |
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers
|
Grann, Victor R. |
|
2010 |
125 |
3 |
p. 837-847 |
artikel |
10 |
COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients
|
Nes, Johanna G. H. van |
|
2010 |
125 |
3 |
p. 671-685 |
artikel |
11 |
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
|
Effenberger, Katharina E. |
|
2010 |
125 |
3 |
p. 729-738 |
artikel |
12 |
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer
|
Iwamoto, Takayuki |
|
2010 |
125 |
3 |
p. 785-795 |
artikel |
13 |
Disseminated tumor cells: the method is the message
|
Park, John W. |
|
2010 |
125 |
3 |
p. 739-740 |
artikel |
14 |
Endoscopic breast surgery: where are we now and what might the future hold for video-assisted breast surgery?
|
Leff, Daniel Richard |
|
2010 |
125 |
3 |
p. 607-625 |
artikel |
15 |
Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer
|
Schmidt, Marcus |
|
2010 |
125 |
3 |
p. 637-646 |
artikel |
16 |
Evaluation of estrogen and progesterone receptors in non-neoplastic breast tissue of women of reproductive age exposed to tamoxifen and raloxifene: a randomized, double-blind study
|
Rosal, Marta Alves |
|
2010 |
125 |
3 |
p. 797-801 |
artikel |
17 |
Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL® sample preparation
|
Ton, C. C. |
|
2010 |
125 |
3 |
p. 879-883 |
artikel |
18 |
Genomics, histopathology, and the tumor microenvironment: new relationship or old friends re-discovered?
|
Visscher, Daniel W. |
|
2010 |
125 |
3 |
p. 697-698 |
artikel |
19 |
Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells
|
Hiscox, Stephen |
|
2010 |
125 |
3 |
p. 659-669 |
artikel |
20 |
Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene
|
Jin, Wei |
|
2010 |
125 |
3 |
p. 699-713 |
artikel |
21 |
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies
|
Roché, Henri |
|
2010 |
125 |
3 |
p. 755-765 |
artikel |
22 |
Mutations and polymorphic BRCA variants transmission in breast cancer familial members
|
Pilato, Brunella |
|
2010 |
125 |
3 |
p. 651-657 |
artikel |
23 |
One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy
|
Henry, N. Lynn |
|
2010 |
125 |
3 |
p. 751-753 |
artikel |
24 |
Outcomes following local therapy for early-stage breast cancer in non-trial populations
|
Keating, Nancy L. |
|
2010 |
125 |
3 |
p. 803-813 |
artikel |
25 |
Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes
|
Mehta, Madhura S. |
|
2010 |
125 |
3 |
p. 861-868 |
artikel |
26 |
RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies
|
Gao, Lin-Bo |
|
2010 |
125 |
3 |
p. 827-835 |
artikel |
27 |
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer
|
Amadori, Dino |
|
2010 |
125 |
3 |
p. 775-784 |
artikel |
28 |
Supraclavicular recurrence after early breast cancer: a curable condition?
|
Pedersen, Anders N. |
|
2010 |
125 |
3 |
p. 815-822 |
artikel |
29 |
The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers
|
Catucci, Irene |
|
2010 |
125 |
3 |
p. 855-860 |
artikel |
30 |
Triple negative breast cancer: unmet medical needs
|
Pal, Sumanta Kumar |
|
2010 |
125 |
3 |
p. 627-636 |
artikel |
31 |
Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
|
Kruijf, Esther M. de |
|
2010 |
125 |
3 |
p. 687-696 |
artikel |
32 |
Two novel variants in the 3′UTR of the BRCA1 gene in familial breast and/or ovarian cancer
|
Lheureux, Stéphanie |
|
2010 |
125 |
3 |
p. 885-891 |
artikel |
33 |
Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study
|
Prieto-Alhambra, Daniel |
|
2010 |
125 |
3 |
p. 869-878 |
artikel |